94 related articles for article (PubMed ID: 9166122)
1. Normal pancreastatin-like and increased post-glucose insulin levels in young offspring of insulin-resistant non-obese essential hypertensive patients.
Sánchez-Margalet V; Ramos E; Mateo J; Oliván J; Pérez-Cano R; Goberna R
J Endocrinol; 1997 May; 153(2):313-8. PubMed ID: 9166122
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma pancreastatin-like immunoreactivity levels in non-obese patients with essential hypertension.
Sánchez-Margalet V; Valle M; Lobón JA; Maldonado A; Escobar-Jimenez F; Oliván J; Pérez-Cano R; Goberna R
J Hypertens; 1995 Feb; 13(2):251-8. PubMed ID: 7615956
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
Sánchez-Margalet V; Lobón JA; González A; Fernández-Soto ML; Escobar-Jiménez F; Goberna R
Diabetes Care; 1998 Nov; 21(11):1951-4. PubMed ID: 9802749
[TBL] [Abstract][Full Text] [Related]
4. Insulin secretion, sensitivity, and metabolic profile of young healthy offspring of hypertensive parents.
Vlasáková Z; Pelikánová T; Karasová L; Skibová J
Metabolism; 2004 Apr; 53(4):469-75. PubMed ID: 15045694
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in offspring of hypertensive parents.
Beatty OL; Harper R; Sheridan B; Atkinson AB; Bell PM
BMJ; 1993 Jul; 307(6896):92-6. PubMed ID: 8343735
[TBL] [Abstract][Full Text] [Related]
6. Glycogenolytic effect of pancreastatin in the rat.
Sanchez V; Calvo JR; Goberna R
Biosci Rep; 1990 Feb; 10(1):87-91. PubMed ID: 2187544
[TBL] [Abstract][Full Text] [Related]
7. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice.
Ahrén B; Lindskog S; Tatemoto K; Efendić S
Diabetes; 1988 Mar; 37(3):281-5. PubMed ID: 3286328
[TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity and beta-cell function in essential hypertension and normotensive first-degree relatives of hypertensive subjects.
Cabezas-Cerrato J; Garcia-Estevez DA; Araújo-Vilar D
Diabetes Metab; 1997 Nov; 23(5):402-8. PubMed ID: 9416432
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin.
Sánchez-Margalet V; González-Yanes C; Najib S; Santos-Alvarez J
Regul Pept; 2010 Apr; 161(1-3):8-14. PubMed ID: 20184923
[TBL] [Abstract][Full Text] [Related]
10. Basal insulin-level oscillations in normotensive individuals with genetic predisposition to essential hypertension exhibit an irregular pattern.
Andersen UB; Dige-Petersen H; Frandsen EK; Ibsen H; Vølund A
J Hypertens; 1997 Oct; 15(10):1167-73. PubMed ID: 9350591
[TBL] [Abstract][Full Text] [Related]
11. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.
Ferrari P; Weidmann P; Shaw S; Giachino D; Riesen W; Allemann Y; Heynen G
Am J Med; 1991 Dec; 91(6):589-96. PubMed ID: 1750428
[TBL] [Abstract][Full Text] [Related]
12. Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.
Sánchez-Margalet V; Calvo JR; Lucas M; Goberna R
Gen Pharmacol; 1992 Jul; 23(4):637-8. PubMed ID: 1397969
[TBL] [Abstract][Full Text] [Related]
13. Insulin sensitivity in normotensive offspring of hypertensive parents.
Chen HS; Hwu CM; Kwok CF; Shih KC; Hsiao LC; Lee SH; Lin YT; Lin SH; Ho LT
Horm Metab Res; 2000 Mar; 32(3):110-4. PubMed ID: 10786930
[TBL] [Abstract][Full Text] [Related]
14. Galanin and pancreastatin inhibit stimulated insulin secretion in the mouse: comparison of effects.
Lindskog S; Ahrén B
Horm Res; 1988; 29(5-6):237-40. PubMed ID: 2464535
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM).
Funakoshi A; Tateishi K; Shinozaki H; Matsumoto M; Wakasugi H
Regul Pept; 1990 Sep; 30(2):159-64. PubMed ID: 2274680
[TBL] [Abstract][Full Text] [Related]
16. Increased fibrinogen levels in the offspring of hypertensive men. Relation with hyperinsulinemia and the metabolic syndrome.
Válek J; Válková L; Vlasáková Z; Topinka V
Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2229-33. PubMed ID: 7489247
[TBL] [Abstract][Full Text] [Related]
17. Studies of the dysglycemic peptide, pancreastatin, using a human forearm model.
Cadman PE; Rao F; Mahata SK; O'Connor DT
Ann N Y Acad Sci; 2002 Oct; 971():528-9. PubMed ID: 12438174
[TBL] [Abstract][Full Text] [Related]
18. Leisure time physical activity and insulin resistance in young obese students with hypertension.
Saito I; Nishino M; Kawabe H; Wainai H; Hasegawa C; Saruta T; Nagano S; Sekihara T
Am J Hypertens; 1992 Dec; 5(12 Pt 1):915-8. PubMed ID: 1285941
[TBL] [Abstract][Full Text] [Related]
19. Hyperinsulinemia and dyslipidemia in non-obese, normotensive offspring of hypertensive parents in northern India.
Misra A; Cherukupalli R; Reddy KS; Mohan A; Bajaj JS
Blood Press; 1998 Nov; 7(5-6):286-90. PubMed ID: 10321441
[TBL] [Abstract][Full Text] [Related]
20. Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin.
Zhang K; Rao F; Wen G; Salem RM; Vaingankar S; Mahata M; Mahapatra NR; Lillie EO; Cadman PE; Friese RS; Hamilton BA; Hook VY; Mahata SK; Taupenot L; O'Connor DT
Diabetes Obes Metab; 2006 Nov; 8(6):621-33. PubMed ID: 17026486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
